Sammy Fang

Sammy Fang

DLA Piper

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Global Anti-Corruption Perspective: A Signal of Further Reform: China Amends Its Anti-Bribery Laws – Key Highlights

The Ninth Amendment to China’s Criminal Law, introducing a new bribery offense and revising anti-bribery and anti-corruption (ABAC) provisions of the law, is now in effect. The ABAC provisions are much wider in coverage than...more

12/11/2015 - Amended Regulation Anti-Bribery Anti-Corruption China Criminal Prosecution Self-Reporting State-Owned Enterprises

Life Sciences Spotlight - Asia Pacific - Issue 6, 2015

Trends and developments in cyber security and data protection: Why pharma and life sciences companies should take action. Pharmaceutical and life sciences companies are increasingly the target of cyber-attacks and...more

12/4/2015 - AstraZeneca Australia Cybersecurity Data Protection Health Care Providers Life Sciences New Zealand Pfizer Pharmaceutical Industry Pharmaceutical Patents Telemedicine

China Regulatory Enforcement Quarterly - Q3 2015

On August 12, a series of explosions in the northern port-city of Tianjin killed over one hundred people and injured hundreds of others. The explosions were allegedly caused by hazardous chemical materials in shipping...more

11/18/2015 - Advertising China Cybersecurity Extradition FCPA Government Investigations Government Officials Medical Devices Multinationals National Security PRC Public Policy Regulatory Agenda

China Regulatory Enforcement Quarterly - Q2 2015

The Chinese regulatory enforcement landscape is still very active for the second quarter of 2015. In the absence of high-profile enforcement actions against Communist Party officials, Chinese authorities appear to be...more

8/13/2015 - China INTERPOL State-Owned Enterprises

Life Sciences Spotlight - Asia Pacific - Issue 5, 2015

In This Issue: - Harper Review Dispenses Important Recommendations For The Life Sciences Sector - Pharmaceutical Patent Term Extensions In Australia - PRC Anti-Corruption Regime 101 - Revisions To The Medicines...more

5/12/2015 - Anti-Corruption Australia Biosimilars China Class Action Code of Conduct Confidential Information Employee Share Schemes Harper Review Life Sciences Patent-Eligible Subject Matter Patents Pharmaceutical Industry Pharmaceutical Patents Veterinary Products

China Regulatory Enforcement Quarterly - Noteworthy developments and insights from the fourth quarter of 2014

In This Issue: - Executive Summary - PRC Legal and Regulatory Updates - Major Enforcement News - The Pharmaceutical Blacklist: A Look Back - After One Year - PRC Anti-Corruption 101 - Frequently Asked...more

1/20/2015 - Anti-Bribery Anti-Corruption APEC China Enforcement Enforcement Actions Pharmaceutical Industry Regulatory Agenda

Life Sciences Spotlight - Issue 4, 2014

Since our last edition, there has been a number of developments in the Life Sciences sector across the Asia Pacific region and we are pleased to be able to update you on these recent trends. It is evident that the...more

8/15/2014 - China Data Protection Life Sciences Medical Devices Patents Right to Privacy Technology

Audit Firm Ordered To Disclose PRC Working Papers To SFC Despite PRC "State Secrets Law" Concerns

On 23 May 2014, the Securities and Futures Commission of Hong Kong ("SFC") successfully obtained an order from the High Court of Hong Kong requiring Ernst & Young Hong Kong ("E&Y") to produce all audit working papers prepared...more

6/3/2014 - Audits Disclosure Ernst & Young Hong Kong SFC State Secrets

Tougher Product Liability Provisions Following The Release Of Long-Awaited Amendments To Consumer Rights And Interests Protection...

OVERVIEW - The rise of consumerism in China over the past ten years, accompanied by huge increases in domestic consumption, has spurred greater regulatory enforcement in the area of product liability, as well as...more

12/5/2013 - China Design Defects Food Safety Manufacturing Defects

The Global Anti-Corruption Perspective - October 2013

CHINA’S NEW WAVE OF REGULATORY ENFORCEMENT: WHAT MULTINATIONALS NEED TO KNOW - Since Xi Jiping became China’s leader this year, the PRC has seen the launch of an unprecedented, sweeping government campaign to tackle...more

10/25/2013 - Anti-Corruption Bribery China Compliance Corporate Gifts Enforcement FCPA Multinationals White Collar Crimes

China's new wave of regulatory enforcement: what multinationals need to know

Since Xi Jiping became China’s leader this year, the PRC has seen the launch of an unprecedented, sweeping government campaign to tackle corruption. The wave of enforcement action against corrupt officials that...more

10/25/2013 - China Compliance Enforcement Multinationals

Life Sciences Spotlight | Issue 3, 2013

IN THIS ISSUE: - FEATURES: - A new wave of regulatory enforcement actions in China – Are we witnessing a prolonged enforcement cycle? - Update on recent decisions - Australia’s innovation patent – The...more

9/5/2013 - Australia Bullying Cartels China Compliance Enforcement Innovation Life Sciences New Regulations Patents Reverse Payment Settlement Agreements

Global Insights - Issue 6, Q2 2013: News, Views and Analysis from DLA Piper’s Global Restructuring Group

In This Issue: - (UK) The Validity Of Exit Consents Under English Law - (UK) When A Charity Faces Financial Difficulty - (UK) Are You At Risk From Financial Distress In Your Supply Chain? - (Global Europe)...more

7/7/2013 - 363 Sales Chapter 11 Charitable Organizations China Commercial Bankruptcy Continuity of Enterprises EU Exit Transactions Multinationals Offshore Companies Restructuring Revlon Supply Chain

14 Results
|
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×